Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Illumina, Inc. is a global leader in providing advanced sequencing and array-based solutions for genetic and genomic analysis. Their main products include instruments, consumables like reagents and flow cells, and various sequencing kits for whole genomes or targeted regions. Illumina serves a broad market including research centers, academic institutions, hospitals, and pharmaceutical and biotechnology companies.
AI-generated summary. Not investment advice.